NCT05641285

Brief Summary

Evaluate clinic workflow impact of OtoSight use for patients seen in the pediatric otolaryngology clinic.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
165

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 17, 2022

Completed
20 days until next milestone

First Posted

Study publicly available on registry

December 7, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

February 21, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 29, 2023

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

October 31, 2024

Status Verified

October 1, 2024

Enrollment Period

4 months

First QC Date

November 17, 2022

Last Update Submit

October 29, 2024

Conditions

Keywords

OtoscopeTympanogram

Outcome Measures

Primary Outcomes (3)

  • Exam Completion Rate

    Compare the successful exam completion rate of these three diagnostic tools. For the Otosight device: presence or absence of visible tympanic membrane, and presence or absence of graph indicating fluid/no fluid in the middle ear. For tympanogram: presence or absence of interpretable tracing indicating normal tympanic membrane movement, retracted tympanic membrane, or no movement of tympanic membrane. For the Otoscope: success is visualization of the tympanic membrane versus unable to see tympanic membrane.

    6 months

  • Detection of middle ear fluid

    Compare the detection of middle ear fluid (versus no fluid) of these diagnostic tools.

    6 months

  • Categorization of middle ear fluid

    Compare the categorization of middle ear fluid (purulent vs. serous vs mucoid) of these diagnostic tools.

    6 months

Secondary Outcomes (1)

  • Timed Evaluation of Clinic Flow

    6 months

Study Arms (1)

Otosight, Otoscope, and Tympanogram

Prospective study using a convenience sample. There will be no group assignment or randomization. There is no intervention planned and therefore, no placebo group or use of controls.

Device: The OtoSight Middle Ear Scope

Interventions

The OtoSight Middle Ear Scope is intended for use as an imaging tool for real-time visualization of the human tympanic membrane and fluid or air within the middle ear space. In the presence of middle ear fluid, the OtoSight Middle Ear Scope is used to visualize the fluid density. The OtoSight Middle Ear Scope is also used to provide surface images of the ear canal and tympanic membrane. It is indicated for use in children and adults.

Otosight, Otoscope, and Tympanogram

Eligibility Criteria

Age6 Months - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Patients aged 6 months to 12 years old who are seen in the outpatient Otolaryngology clinic at Texas Children's Hospital main and west campuses who have no history of ear tube placement.

You may qualify if:

  • Patients aged 6 months to 12 years old who are seen in the outpatient Otolaryngology clinic at Texas Children's Hospital main and west campuses.

You may not qualify if:

  • Patients who have a history of ear tube placement

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Texas Children's Hospital

Houston, Texas, 77030, United States

Location

MeSH Terms

Conditions

OtitisOtitis Media

Condition Hierarchy (Ancestors)

Ear DiseasesOtorhinolaryngologic Diseases

Study Officials

  • Anna Messner, MD

    Baylor College of Medicine

    PRINCIPAL INVESTIGATOR
  • Yi-Chun Liu, MD

    Baylor College of Medicine

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 17, 2022

First Posted

December 7, 2022

Study Start

February 21, 2023

Primary Completion

June 29, 2023

Study Completion

June 30, 2025

Last Updated

October 31, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

No one besides the PI, the study staff, the IRB and the sponsor will have access to identifiable research data.

Locations